⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
JBIO News
Jade Biosciences, Inc. Common Stock
Jade Biosciences to Highlight Advancement of JADE101 Development Program at American Society of Nephrology (ASN) Kidney Week 2026
globenewswire.com
JBIO
Form 8-K
sec.gov
JBIO
Jade Biosciences Announces Preclinical Data Characterizing JADE301, a Potentially Best-in-Class, Half-Life-Extended Anti-IFN-β Monoclonal Antibody in Development for Dermatomyositis, at EADV 2026
globenewswire.com
JBIO
Jade Biosciences to Participate in Upcoming Conferences
globenewswire.com
JBIO
Form 8-K
sec.gov
JBIO
Jade Biosciences Reports Second Quarter 2026 Financial Results and Provides Corporate Update
globenewswire.com
JBIO
Form 8-K
sec.gov
JBIO
Form 8-K
sec.gov
JBIO
Jade Biosciences Announces Appointment of Mark Eisner, M.D., M.P.H., to Board of Directors
globenewswire.com
JBIO
Form 8-K
sec.gov
JBIO